Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5236883
The pharmacodynamics of technetium-99m stannous citrate were studied in Yale--Swiss mice bearing a sarcoma-like transplantable brain tumor, and the renal kinetics were determined in normal mice. Using a rating system based on tumor uptake and tumor-to-brain, tumor-to-blood, and tumor-to-skin ratios, the data obtained with this compound were compared with similar data obtained previously in the same model with Tc-99m Fe-(ascorbic acid), Tc-99m Fe-(ascorbic acid)-DTPA, Tc-99m Sn-DTPA, (/sup 99m/Tc) pertechnetate, and (/sup 99m/Tc) pertechnetate with perchlorate predose. Technetium-99m stannous citrate does not appear to achieve tumor localization by a mode different from these other Tc-99m-labeled compounds, nor does it show any potential advantage as a scanning agent in this tumor model.
Research Organization:
Univ. of Texas System Cancer Center, Houston
OSTI ID:
5236883
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 18:9; ISSN JNMEA
Country of Publication:
United States
Language:
English